Francis M. Senecal
Northwest Medical Specialties(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial(2008)853 cited
- → Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial(2017)580 cited
- → Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer(2012)466 cited
- → Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial(2020)211 cited
- → Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial(2015)151 cited
- → Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations(2022)95 cited
- → Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial(2019)25 cited
- → A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer(2016)22 cited
- → S899 INHIBITION OF C3 WITH APL‐2 CONTROLS HAEMOLYSIS AND INCREASES HAEMOGLOBIN LEVELS IN SUBJECTS WITH AUTOIMMUNE HAEMOLYTIC ANAEMIA (AIHA)(2019)13 cited